Scientific Evidence & Publications
Poster
DeepOmic, a self-supervised multi-omic AI foundation model, identifies prognostic subgroups across solid tumours
Abstract 2737
ESMO 2026 · Madrid · Oct 2026
Poster
A pretrained multi-omic AI foundation model identifies eight prognostically distinct breast cancer subgroups in METABRIC
Abstract 7878
ESMO 2026 · Madrid · Oct 2026
Poster
Matched-cohort comparison of multi-omic representation learning methods under a leakage-free held-out-patient protocol
Abstract 569
ESMO 2026 · Berlin · Nov 2026
Poster
Transcriptome-only DeepOmic preserves clinically relevant survival prediction without comprehensive multi-omic profiling
Abstract 573
ESMO 2026 · Berlin · Nov 2026
Poster
Pan-cancer reconstruction performance can materially overestimate patient-relevant, within-disease performance
Abstract 607
ESMO 2026 · Berlin · Nov 2026
Poster
Multi-omic AI Embeddings from Routine DNA Panels Stratify Mortality Risk in MAPK-activated Breast Cancer
2
WIN 2026 · Rhode Island · Oct 2026
Poster
Systematic multiomics ablation identities copy-number alteration as the dominant portable and response associated biomarker of triple negative breast cancer biology
2
SABCS 2026 · San Antonio · Dec 2026
Poster
Pathway-guided multi-omic AI reconstructs missing RNA and DNA methylation profiles across 34 cancer types
Abstract 7766
ESMO 2026 · Madrid · Oct 2026
Poster
Multi-omic AI stratifies survival in immunotherapy-treated metastatic pancreatic cancer from the PRINCE phase 2 trial
Abstract 7967
ESMO 2026 · Madrid · Oct 2026
Poster
Zero-shot survival prediction in tumour histologies unseen during multi-omic foundation-model pretraining
Abstract 570
ESMO 2026 · Berlin · Nov 2026
Poster
A generative omics engine recovers transcriptomic biology from a single molecular assay, enabling assay-sparing precision oncology
Abstract 574
ESMO 2026 · Berlin · Nov 2026
Poster
Biological graph priors enable zero-shot prediction of CRISPR perturbation effects by a pan-cancer generative omics model
Abstract 610
ESMO 2026 · Berlin · Nov 2026
Poster
Transcriptome-derived multi-omic AI signature predicts survival in anti-PD-1/PD-L1-treated melanoma
3
WIN 2026 · Rhode Island · Oct 2026
Poster
DNA-only multi-omic AI identifies tumour primary site across 31 lineages in cancer of unknown primary
Abstract 7824
ESMO 2026 · Madrid · Oct 2026
Poster
A tumor agnostic multi-omic foundation model for zero-shot generalisation, low-label transfer and clinically relevant prediction
Abstract 564
ESMO 2026 · Berlin · Nov 2026
Poster
A tumor-agnostic multi-omic foundation model enriches for immunotherapy responders within PD-L1-low tumours
Abstract 571
ESMO 2026 · Berlin · Nov 2026
Poster
A generative omics engine operates across incomplete molecular profiles without requiring a fixed assay panel
Abstract 593
ESMO 2026 · Berlin · Nov 2026
Poster
Beyond Conventional Biomarkers: Multi-Omic Foundation Models Reveal Prognostic Patient States Across Solid Tumours
1
WIN 2026 · Rhode Island · Oct 2026
Poster
A pan-cancer multiomics foundation model identifies copy-number instability as the dominant negative breast cancer to ovarian cancer and uterine carcinoma
1
SABCS 2026 · San Antonio · Dec 2026
Poster
DeepOmic, a self-supervised multi-omic AI foundation model, identifies prognostic subgroups across solid tumours
Abstract 2737
ESMO 2026 · Madrid · Oct 2026
Poster
Pathway-guided multi-omic AI reconstructs missing RNA and DNA methylation profiles across 34 cancer types
Abstract 7766
ESMO 2026 · Madrid · Oct 2026
Poster
DNA-only multi-omic AI identifies tumour primary site across 31 lineages in cancer of unknown primary
Abstract 7824
ESMO 2026 · Madrid · Oct 2026
Poster
A pretrained multi-omic AI foundation model identifies eight prognostically distinct breast cancer subgroups in METABRIC
Abstract 7878
ESMO 2026 · Madrid · Oct 2026
Poster
Multi-omic AI stratifies survival in immunotherapy-treated metastatic pancreatic cancer from the PRINCE phase 2 trial
Abstract 7967
ESMO 2026 · Madrid · Oct 2026
Poster
A tumor agnostic multi-omic foundation model for zero-shot generalisation, low-label transfer and clinically relevant prediction
Abstract 564
ESMO 2026 · Berlin · Nov 2026
Poster
Matched-cohort comparison of multi-omic representation learning methods under a leakage-free held-out-patient protocol
Abstract 569
ESMO 2026 · Berlin · Nov 2026
Poster
Zero-shot survival prediction in tumour histologies unseen during multi-omic foundation-model pretraining
Abstract 570
ESMO 2026 · Berlin · Nov 2026
Poster
A tumor-agnostic multi-omic foundation model enriches for immunotherapy responders within PD-L1-low tumours
Abstract 571
ESMO 2026 · Berlin · Nov 2026
Poster
Transcriptome-only DeepOmic preserves clinically relevant survival prediction without comprehensive multi-omic profiling
Abstract 573
ESMO 2026 · Berlin · Nov 2026
Poster
A generative omics engine recovers transcriptomic biology from a single molecular assay, enabling assay-sparing precision oncology
Abstract 574
ESMO 2026 · Berlin · Nov 2026
Poster
A generative omics engine operates across incomplete molecular profiles without requiring a fixed assay panel
Abstract 593
ESMO 2026 · Berlin · Nov 2026
Poster
Pan-cancer reconstruction performance can materially overestimate patient-relevant, within-disease performance
Abstract 607
ESMO 2026 · Berlin · Nov 2026
Poster
Biological graph priors enable zero-shot prediction of CRISPR perturbation effects by a pan-cancer generative omics model
Abstract 610
ESMO 2026 · Berlin · Nov 2026
Poster
Beyond Conventional Biomarkers: Multi-Omic Foundation Models Reveal Prognostic Patient States Across Solid Tumours
1
WIN 2026 · Rhode Island · Oct 2026
Poster
Multi-omic AI Embeddings from Routine DNA Panels Stratify Mortality Risk in MAPK-activated Breast Cancer
2
WIN 2026 · Rhode Island · Oct 2026
Poster
Transcriptome-derived multi-omic AI signature predicts survival in anti-PD-1/PD-L1-treated melanoma
3
WIN 2026 · Rhode Island · Oct 2026
Poster
A pan-cancer multiomics foundation model identifies copy-number instability as the dominant negative breast cancer to ovarian cancer and uterine carcinoma
1
SABCS 2026 · San Antonio · Dec 2026
Poster
Systematic multiomics ablation identities copy-number alteration as the dominant portable and response associated biomarker of triple negative breast cancer biology
2
SABCS 2026 · San Antonio · Dec 2026
Poster
DeepOmic, a self-supervised multi-omic AI foundation model, identifies prognostic subgroups across solid tumours
Abstract 2737
ESMO 2026 · Madrid · Oct 2026
Poster
DNA-only multi-omic AI identifies tumour primary site across 31 lineages in cancer of unknown primary
Abstract 7824
ESMO 2026 · Madrid · Oct 2026
Poster
Multi-omic AI stratifies survival in immunotherapy-treated metastatic pancreatic cancer from the PRINCE phase 2 trial
Abstract 7967
ESMO 2026 · Madrid · Oct 2026
Poster
Matched-cohort comparison of multi-omic representation learning methods under a leakage-free held-out-patient protocol
Abstract 569
ESMO 2026 · Berlin · Nov 2026
Poster
A tumor-agnostic multi-omic foundation model enriches for immunotherapy responders within PD-L1-low tumours
Abstract 571
ESMO 2026 · Berlin · Nov 2026
Poster
A generative omics engine recovers transcriptomic biology from a single molecular assay, enabling assay-sparing precision oncology
Abstract 574
ESMO 2026 · Berlin · Nov 2026
Poster
Pan-cancer reconstruction performance can materially overestimate patient-relevant, within-disease performance
Abstract 607
ESMO 2026 · Berlin · Nov 2026
Poster
Beyond Conventional Biomarkers: Multi-Omic Foundation Models Reveal Prognostic Patient States Across Solid Tumours
1
WIN 2026 · Rhode Island · Oct 2026
Poster
Transcriptome-derived multi-omic AI signature predicts survival in anti-PD-1/PD-L1-treated melanoma
3
WIN 2026 · Rhode Island · Oct 2026
Poster
Systematic multiomics ablation identities copy-number alteration as the dominant portable and response associated biomarker of triple negative breast cancer biology
2
SABCS 2026 · San Antonio · Dec 2026
Poster
Pathway-guided multi-omic AI reconstructs missing RNA and DNA methylation profiles across 34 cancer types
Abstract 7766
ESMO 2026 · Madrid · Oct 2026
Poster
A pretrained multi-omic AI foundation model identifies eight prognostically distinct breast cancer subgroups in METABRIC
Abstract 7878
ESMO 2026 · Madrid · Oct 2026
Poster
A tumor agnostic multi-omic foundation model for zero-shot generalisation, low-label transfer and clinically relevant prediction
Abstract 564
ESMO 2026 · Berlin · Nov 2026
Poster
Zero-shot survival prediction in tumour histologies unseen during multi-omic foundation-model pretraining
Abstract 570
ESMO 2026 · Berlin · Nov 2026
Poster
Transcriptome-only DeepOmic preserves clinically relevant survival prediction without comprehensive multi-omic profiling
Abstract 573
ESMO 2026 · Berlin · Nov 2026
Poster
A generative omics engine operates across incomplete molecular profiles without requiring a fixed assay panel
Abstract 593
ESMO 2026 · Berlin · Nov 2026
Poster
Biological graph priors enable zero-shot prediction of CRISPR perturbation effects by a pan-cancer generative omics model
Abstract 610
ESMO 2026 · Berlin · Nov 2026
Poster
Multi-omic AI Embeddings from Routine DNA Panels Stratify Mortality Risk in MAPK-activated Breast Cancer
2
WIN 2026 · Rhode Island · Oct 2026
Poster
A pan-cancer multiomics foundation model identifies copy-number instability as the dominant negative breast cancer to ovarian cancer and uterine carcinoma
1
SABCS 2026 · San Antonio · Dec 2026
The Greenway, Block C,
112-114 St Stephen's Green,
Dublin 2, D02 TD28
Dublin, Ireland
Scientific Evidence & Publications
Poster
DeepOmic, a self-supervised multi-omic AI foundation model, identifies prognostic subgroups across solid tumours
Abstract 2737
ESMO 2026 · Madrid · Oct 2026
Poster
A pretrained multi-omic AI foundation model identifies eight prognostically distinct breast cancer subgroups in METABRIC
Abstract 7878
ESMO 2026 · Madrid · Oct 2026
Poster
Matched-cohort comparison of multi-omic representation learning methods under a leakage-free held-out-patient protocol
Abstract 569
ESMO 2026 · Berlin · Nov 2026
Poster
Transcriptome-only DeepOmic preserves clinically relevant survival prediction without comprehensive multi-omic profiling
Abstract 573
ESMO 2026 · Berlin · Nov 2026
Poster
Pan-cancer reconstruction performance can materially overestimate patient-relevant, within-disease performance
Abstract 607
ESMO 2026 · Berlin · Nov 2026
Poster
Multi-omic AI Embeddings from Routine DNA Panels Stratify Mortality Risk in MAPK-activated Breast Cancer
2
WIN 2026 · Rhode Island · Oct 2026
Poster
Systematic multiomics ablation identities copy-number alteration as the dominant portable and response associated biomarker of triple negative breast cancer biology
2
SABCS 2026 · San Antonio · Dec 2026
Poster
Pathway-guided multi-omic AI reconstructs missing RNA and DNA methylation profiles across 34 cancer types
Abstract 7766
ESMO 2026 · Madrid · Oct 2026
Poster
Multi-omic AI stratifies survival in immunotherapy-treated metastatic pancreatic cancer from the PRINCE phase 2 trial
Abstract 7967
ESMO 2026 · Madrid · Oct 2026
Poster
Zero-shot survival prediction in tumour histologies unseen during multi-omic foundation-model pretraining
Abstract 570
ESMO 2026 · Berlin · Nov 2026
Poster
A generative omics engine recovers transcriptomic biology from a single molecular assay, enabling assay-sparing precision oncology
Abstract 574
ESMO 2026 · Berlin · Nov 2026
Poster
Biological graph priors enable zero-shot prediction of CRISPR perturbation effects by a pan-cancer generative omics model
Abstract 610
ESMO 2026 · Berlin · Nov 2026
Poster
Transcriptome-derived multi-omic AI signature predicts survival in anti-PD-1/PD-L1-treated melanoma
3
WIN 2026 · Rhode Island · Oct 2026
Poster
DNA-only multi-omic AI identifies tumour primary site across 31 lineages in cancer of unknown primary
Abstract 7824
ESMO 2026 · Madrid · Oct 2026
Poster
A tumor agnostic multi-omic foundation model for zero-shot generalisation, low-label transfer and clinically relevant prediction
Abstract 564
ESMO 2026 · Berlin · Nov 2026
Poster
A tumor-agnostic multi-omic foundation model enriches for immunotherapy responders within PD-L1-low tumours
Abstract 571
ESMO 2026 · Berlin · Nov 2026
Poster
A generative omics engine operates across incomplete molecular profiles without requiring a fixed assay panel
Abstract 593
ESMO 2026 · Berlin · Nov 2026
Poster
Beyond Conventional Biomarkers: Multi-Omic Foundation Models Reveal Prognostic Patient States Across Solid Tumours
1
WIN 2026 · Rhode Island · Oct 2026
Poster
A pan-cancer multiomics foundation model identifies copy-number instability as the dominant negative breast cancer to ovarian cancer and uterine carcinoma
1
SABCS 2026 · San Antonio · Dec 2026
Poster
DeepOmic, a self-supervised multi-omic AI foundation model, identifies prognostic subgroups across solid tumours
Abstract 2737
ESMO 2026 · Madrid · Oct 2026
Poster
Pathway-guided multi-omic AI reconstructs missing RNA and DNA methylation profiles across 34 cancer types
Abstract 7766
ESMO 2026 · Madrid · Oct 2026
Poster
DNA-only multi-omic AI identifies tumour primary site across 31 lineages in cancer of unknown primary
Abstract 7824
ESMO 2026 · Madrid · Oct 2026
Poster
A pretrained multi-omic AI foundation model identifies eight prognostically distinct breast cancer subgroups in METABRIC
Abstract 7878
ESMO 2026 · Madrid · Oct 2026
Poster
Multi-omic AI stratifies survival in immunotherapy-treated metastatic pancreatic cancer from the PRINCE phase 2 trial
Abstract 7967
ESMO 2026 · Madrid · Oct 2026
Poster
A tumor agnostic multi-omic foundation model for zero-shot generalisation, low-label transfer and clinically relevant prediction
Abstract 564
ESMO 2026 · Berlin · Nov 2026
Poster
Matched-cohort comparison of multi-omic representation learning methods under a leakage-free held-out-patient protocol
Abstract 569
ESMO 2026 · Berlin · Nov 2026
Poster
Zero-shot survival prediction in tumour histologies unseen during multi-omic foundation-model pretraining
Abstract 570
ESMO 2026 · Berlin · Nov 2026
Poster
A tumor-agnostic multi-omic foundation model enriches for immunotherapy responders within PD-L1-low tumours
Abstract 571
ESMO 2026 · Berlin · Nov 2026
Poster
Transcriptome-only DeepOmic preserves clinically relevant survival prediction without comprehensive multi-omic profiling
Abstract 573
ESMO 2026 · Berlin · Nov 2026
Poster
A generative omics engine recovers transcriptomic biology from a single molecular assay, enabling assay-sparing precision oncology
Abstract 574
ESMO 2026 · Berlin · Nov 2026
Poster
A generative omics engine operates across incomplete molecular profiles without requiring a fixed assay panel
Abstract 593
ESMO 2026 · Berlin · Nov 2026
Poster
Pan-cancer reconstruction performance can materially overestimate patient-relevant, within-disease performance
Abstract 607
ESMO 2026 · Berlin · Nov 2026
Poster
Biological graph priors enable zero-shot prediction of CRISPR perturbation effects by a pan-cancer generative omics model
Abstract 610
ESMO 2026 · Berlin · Nov 2026
Poster
Beyond Conventional Biomarkers: Multi-Omic Foundation Models Reveal Prognostic Patient States Across Solid Tumours
1
WIN 2026 · Rhode Island · Oct 2026
Poster
Multi-omic AI Embeddings from Routine DNA Panels Stratify Mortality Risk in MAPK-activated Breast Cancer
2
WIN 2026 · Rhode Island · Oct 2026
Poster
Transcriptome-derived multi-omic AI signature predicts survival in anti-PD-1/PD-L1-treated melanoma
3
WIN 2026 · Rhode Island · Oct 2026
Poster
A pan-cancer multiomics foundation model identifies copy-number instability as the dominant negative breast cancer to ovarian cancer and uterine carcinoma
1
SABCS 2026 · San Antonio · Dec 2026
Poster
Systematic multiomics ablation identities copy-number alteration as the dominant portable and response associated biomarker of triple negative breast cancer biology
2
SABCS 2026 · San Antonio · Dec 2026
Poster
DeepOmic, a self-supervised multi-omic AI foundation model, identifies prognostic subgroups across solid tumours
Abstract 2737
ESMO 2026 · Madrid · Oct 2026
Poster
DNA-only multi-omic AI identifies tumour primary site across 31 lineages in cancer of unknown primary
Abstract 7824
ESMO 2026 · Madrid · Oct 2026
Poster
Multi-omic AI stratifies survival in immunotherapy-treated metastatic pancreatic cancer from the PRINCE phase 2 trial
Abstract 7967
ESMO 2026 · Madrid · Oct 2026
Poster
Matched-cohort comparison of multi-omic representation learning methods under a leakage-free held-out-patient protocol
Abstract 569
ESMO 2026 · Berlin · Nov 2026
Poster
A tumor-agnostic multi-omic foundation model enriches for immunotherapy responders within PD-L1-low tumours
Abstract 571
ESMO 2026 · Berlin · Nov 2026
Poster
A generative omics engine recovers transcriptomic biology from a single molecular assay, enabling assay-sparing precision oncology
Abstract 574
ESMO 2026 · Berlin · Nov 2026
Poster
Pan-cancer reconstruction performance can materially overestimate patient-relevant, within-disease performance
Abstract 607
ESMO 2026 · Berlin · Nov 2026
Poster
Beyond Conventional Biomarkers: Multi-Omic Foundation Models Reveal Prognostic Patient States Across Solid Tumours
1
WIN 2026 · Rhode Island · Oct 2026
Poster
Transcriptome-derived multi-omic AI signature predicts survival in anti-PD-1/PD-L1-treated melanoma
3
WIN 2026 · Rhode Island · Oct 2026
Poster
Systematic multiomics ablation identities copy-number alteration as the dominant portable and response associated biomarker of triple negative breast cancer biology
2
SABCS 2026 · San Antonio · Dec 2026
Poster
Pathway-guided multi-omic AI reconstructs missing RNA and DNA methylation profiles across 34 cancer types
Abstract 7766
ESMO 2026 · Madrid · Oct 2026
Poster
A pretrained multi-omic AI foundation model identifies eight prognostically distinct breast cancer subgroups in METABRIC
Abstract 7878
ESMO 2026 · Madrid · Oct 2026
Poster
A tumor agnostic multi-omic foundation model for zero-shot generalisation, low-label transfer and clinically relevant prediction
Abstract 564
ESMO 2026 · Berlin · Nov 2026
Poster
Zero-shot survival prediction in tumour histologies unseen during multi-omic foundation-model pretraining
Abstract 570
ESMO 2026 · Berlin · Nov 2026
Poster
Transcriptome-only DeepOmic preserves clinically relevant survival prediction without comprehensive multi-omic profiling
Abstract 573
ESMO 2026 · Berlin · Nov 2026
Poster
A generative omics engine operates across incomplete molecular profiles without requiring a fixed assay panel
Abstract 593
ESMO 2026 · Berlin · Nov 2026
Poster
Biological graph priors enable zero-shot prediction of CRISPR perturbation effects by a pan-cancer generative omics model
Abstract 610
ESMO 2026 · Berlin · Nov 2026
Poster
Multi-omic AI Embeddings from Routine DNA Panels Stratify Mortality Risk in MAPK-activated Breast Cancer
2
WIN 2026 · Rhode Island · Oct 2026
Poster
A pan-cancer multiomics foundation model identifies copy-number instability as the dominant negative breast cancer to ovarian cancer and uterine carcinoma
1
SABCS 2026 · San Antonio · Dec 2026
The Greenway, Block C,
112-114 St Stephen's Green,
Dublin 2, D02 TD28
Dublin, Ireland
Scientific Evidence & Publications
Poster
DeepOmic, a self-supervised multi-omic AI foundation model, identifies prognostic subgroups across solid tumours
Abstract 2737
ESMO 2026 · Madrid · Oct 2026
Poster
A pretrained multi-omic AI foundation model identifies eight prognostically distinct breast cancer subgroups in METABRIC
Abstract 7878
ESMO 2026 · Madrid · Oct 2026
Poster
Matched-cohort comparison of multi-omic representation learning methods under a leakage-free held-out-patient protocol
Abstract 569
ESMO 2026 · Berlin · Nov 2026
Poster
Transcriptome-only DeepOmic preserves clinically relevant survival prediction without comprehensive multi-omic profiling
Abstract 573
ESMO 2026 · Berlin · Nov 2026
Poster
Pan-cancer reconstruction performance can materially overestimate patient-relevant, within-disease performance
Abstract 607
ESMO 2026 · Berlin · Nov 2026
Poster
Multi-omic AI Embeddings from Routine DNA Panels Stratify Mortality Risk in MAPK-activated Breast Cancer
2
WIN 2026 · Rhode Island · Oct 2026
Poster
Systematic multiomics ablation identities copy-number alteration as the dominant portable and response associated biomarker of triple negative breast cancer biology
2
SABCS 2026 · San Antonio · Dec 2026
Poster
Pathway-guided multi-omic AI reconstructs missing RNA and DNA methylation profiles across 34 cancer types
Abstract 7766
ESMO 2026 · Madrid · Oct 2026
Poster
Multi-omic AI stratifies survival in immunotherapy-treated metastatic pancreatic cancer from the PRINCE phase 2 trial
Abstract 7967
ESMO 2026 · Madrid · Oct 2026
Poster
Zero-shot survival prediction in tumour histologies unseen during multi-omic foundation-model pretraining
Abstract 570
ESMO 2026 · Berlin · Nov 2026
Poster
A generative omics engine recovers transcriptomic biology from a single molecular assay, enabling assay-sparing precision oncology
Abstract 574
ESMO 2026 · Berlin · Nov 2026
Poster
Biological graph priors enable zero-shot prediction of CRISPR perturbation effects by a pan-cancer generative omics model
Abstract 610
ESMO 2026 · Berlin · Nov 2026
Poster
Transcriptome-derived multi-omic AI signature predicts survival in anti-PD-1/PD-L1-treated melanoma
3
WIN 2026 · Rhode Island · Oct 2026
Poster
DNA-only multi-omic AI identifies tumour primary site across 31 lineages in cancer of unknown primary
Abstract 7824
ESMO 2026 · Madrid · Oct 2026
Poster
A tumor agnostic multi-omic foundation model for zero-shot generalisation, low-label transfer and clinically relevant prediction
Abstract 564
ESMO 2026 · Berlin · Nov 2026
Poster
A tumor-agnostic multi-omic foundation model enriches for immunotherapy responders within PD-L1-low tumours
Abstract 571
ESMO 2026 · Berlin · Nov 2026
Poster
A generative omics engine operates across incomplete molecular profiles without requiring a fixed assay panel
Abstract 593
ESMO 2026 · Berlin · Nov 2026
Poster
Beyond Conventional Biomarkers: Multi-Omic Foundation Models Reveal Prognostic Patient States Across Solid Tumours
1
WIN 2026 · Rhode Island · Oct 2026
Poster
A pan-cancer multiomics foundation model identifies copy-number instability as the dominant negative breast cancer to ovarian cancer and uterine carcinoma
1
SABCS 2026 · San Antonio · Dec 2026
Poster
DeepOmic, a self-supervised multi-omic AI foundation model, identifies prognostic subgroups across solid tumours
Abstract 2737
ESMO 2026 · Madrid · Oct 2026
Poster
Pathway-guided multi-omic AI reconstructs missing RNA and DNA methylation profiles across 34 cancer types
Abstract 7766
ESMO 2026 · Madrid · Oct 2026
Poster
DNA-only multi-omic AI identifies tumour primary site across 31 lineages in cancer of unknown primary
Abstract 7824
ESMO 2026 · Madrid · Oct 2026
Poster
A pretrained multi-omic AI foundation model identifies eight prognostically distinct breast cancer subgroups in METABRIC
Abstract 7878
ESMO 2026 · Madrid · Oct 2026
Poster
Multi-omic AI stratifies survival in immunotherapy-treated metastatic pancreatic cancer from the PRINCE phase 2 trial
Abstract 7967
ESMO 2026 · Madrid · Oct 2026
Poster
A tumor agnostic multi-omic foundation model for zero-shot generalisation, low-label transfer and clinically relevant prediction
Abstract 564
ESMO 2026 · Berlin · Nov 2026
Poster
Matched-cohort comparison of multi-omic representation learning methods under a leakage-free held-out-patient protocol
Abstract 569
ESMO 2026 · Berlin · Nov 2026
Poster
Zero-shot survival prediction in tumour histologies unseen during multi-omic foundation-model pretraining
Abstract 570
ESMO 2026 · Berlin · Nov 2026
Poster
A tumor-agnostic multi-omic foundation model enriches for immunotherapy responders within PD-L1-low tumours
Abstract 571
ESMO 2026 · Berlin · Nov 2026
Poster
Transcriptome-only DeepOmic preserves clinically relevant survival prediction without comprehensive multi-omic profiling
Abstract 573
ESMO 2026 · Berlin · Nov 2026
Poster
A generative omics engine recovers transcriptomic biology from a single molecular assay, enabling assay-sparing precision oncology
Abstract 574
ESMO 2026 · Berlin · Nov 2026
Poster
A generative omics engine operates across incomplete molecular profiles without requiring a fixed assay panel
Abstract 593
ESMO 2026 · Berlin · Nov 2026
Poster
Pan-cancer reconstruction performance can materially overestimate patient-relevant, within-disease performance
Abstract 607
ESMO 2026 · Berlin · Nov 2026
Poster
Biological graph priors enable zero-shot prediction of CRISPR perturbation effects by a pan-cancer generative omics model
Abstract 610
ESMO 2026 · Berlin · Nov 2026
Poster
Beyond Conventional Biomarkers: Multi-Omic Foundation Models Reveal Prognostic Patient States Across Solid Tumours
1
WIN 2026 · Rhode Island · Oct 2026
Poster
Multi-omic AI Embeddings from Routine DNA Panels Stratify Mortality Risk in MAPK-activated Breast Cancer
2
WIN 2026 · Rhode Island · Oct 2026
Poster
Transcriptome-derived multi-omic AI signature predicts survival in anti-PD-1/PD-L1-treated melanoma
3
WIN 2026 · Rhode Island · Oct 2026
Poster
A pan-cancer multiomics foundation model identifies copy-number instability as the dominant negative breast cancer to ovarian cancer and uterine carcinoma
1
SABCS 2026 · San Antonio · Dec 2026
Poster
Systematic multiomics ablation identities copy-number alteration as the dominant portable and response associated biomarker of triple negative breast cancer biology
2
SABCS 2026 · San Antonio · Dec 2026
Poster
DeepOmic, a self-supervised multi-omic AI foundation model, identifies prognostic subgroups across solid tumours
Abstract 2737
ESMO 2026 · Madrid · Oct 2026
Poster
DNA-only multi-omic AI identifies tumour primary site across 31 lineages in cancer of unknown primary
Abstract 7824
ESMO 2026 · Madrid · Oct 2026
Poster
Multi-omic AI stratifies survival in immunotherapy-treated metastatic pancreatic cancer from the PRINCE phase 2 trial
Abstract 7967
ESMO 2026 · Madrid · Oct 2026
Poster
Matched-cohort comparison of multi-omic representation learning methods under a leakage-free held-out-patient protocol
Abstract 569
ESMO 2026 · Berlin · Nov 2026
Poster
A tumor-agnostic multi-omic foundation model enriches for immunotherapy responders within PD-L1-low tumours
Abstract 571
ESMO 2026 · Berlin · Nov 2026
Poster
A generative omics engine recovers transcriptomic biology from a single molecular assay, enabling assay-sparing precision oncology
Abstract 574
ESMO 2026 · Berlin · Nov 2026
Poster
Pan-cancer reconstruction performance can materially overestimate patient-relevant, within-disease performance
Abstract 607
ESMO 2026 · Berlin · Nov 2026
Poster
Beyond Conventional Biomarkers: Multi-Omic Foundation Models Reveal Prognostic Patient States Across Solid Tumours
1
WIN 2026 · Rhode Island · Oct 2026
Poster
Transcriptome-derived multi-omic AI signature predicts survival in anti-PD-1/PD-L1-treated melanoma
3
WIN 2026 · Rhode Island · Oct 2026
Poster
Systematic multiomics ablation identities copy-number alteration as the dominant portable and response associated biomarker of triple negative breast cancer biology
2
SABCS 2026 · San Antonio · Dec 2026
Poster
Pathway-guided multi-omic AI reconstructs missing RNA and DNA methylation profiles across 34 cancer types
Abstract 7766
ESMO 2026 · Madrid · Oct 2026
Poster
A pretrained multi-omic AI foundation model identifies eight prognostically distinct breast cancer subgroups in METABRIC
Abstract 7878
ESMO 2026 · Madrid · Oct 2026
Poster
A tumor agnostic multi-omic foundation model for zero-shot generalisation, low-label transfer and clinically relevant prediction
Abstract 564
ESMO 2026 · Berlin · Nov 2026
Poster
Zero-shot survival prediction in tumour histologies unseen during multi-omic foundation-model pretraining
Abstract 570
ESMO 2026 · Berlin · Nov 2026
Poster
Transcriptome-only DeepOmic preserves clinically relevant survival prediction without comprehensive multi-omic profiling
Abstract 573
ESMO 2026 · Berlin · Nov 2026
Poster
A generative omics engine operates across incomplete molecular profiles without requiring a fixed assay panel
Abstract 593
ESMO 2026 · Berlin · Nov 2026
Poster
Biological graph priors enable zero-shot prediction of CRISPR perturbation effects by a pan-cancer generative omics model
Abstract 610
ESMO 2026 · Berlin · Nov 2026
Poster
Multi-omic AI Embeddings from Routine DNA Panels Stratify Mortality Risk in MAPK-activated Breast Cancer
2
WIN 2026 · Rhode Island · Oct 2026
Poster
A pan-cancer multiomics foundation model identifies copy-number instability as the dominant negative breast cancer to ovarian cancer and uterine carcinoma
1
SABCS 2026 · San Antonio · Dec 2026
The Greenway, Block C,
112-114 St Stephen's Green,
Dublin 2, D02 TD28
Dublin, Ireland